₹174.06*
MRP ₹197.8
12% off
₹174.06*
MRP ₹197.8
12% CB
₹23.74 cashback(12%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
Composition :
CAMYLOFIN-50MG + MEFENAMIC ACID-250MG
Manufacturer/Marketer :
Manking
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Bigspas M Tablet:
Co-administration of Bigspas M Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Bigspas M Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Co-administration of Bigspas M Tablet with Meloxicam together can increase the risk or severity of bleeding.
How to manage the interaction:
Taking Bigspas M Tablet with Meloxicam together is generally avoided as it can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking a doctor.
Critical
How does the drug interact with Bigspas M Tablet:
Coadministration of Bigspas M Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Bigspas M Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Bigspas M Tablet with Ketorolac can increase the risk or severity of gastric bleeding and ulcers.
How to manage the interaction:
Taking Bigspas M Tablet with Ketorolac together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Bigspas M Tablet:
Co-administration of Bigspas M Tablet with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Bigspas M Tablet with Prasugrel can increase the risk or severity of gastric bleeding, ulceration, and rarely, perforation leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Prasugrel together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Bigspas M Tablet:
Teriflunomide may cause liver damage and taking it with Bigspas M Tablet may increase that risk.
How to manage the interaction:
Although taking Bigspas M Tablet and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
Teriflunomide may cause liver damage and taking it with Bigspas M Tablet may increase that risk.
How to manage the interaction:
Although taking Bigspas M Tablet and Teriflunomide together can cause an interaction, it can be taken if your doctor has suggested it. If you have any of these symptoms, it's important to contact your doctor right away - liver problems, fever, feeling cold, pain in your joints, swelling, bruises, rash, itchy skin, not feeling hungry, feeling tired, feeling sick, throwing up, dark urine, or bleeding. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Bigspas M Tablet:
Coadministration of Bigspas M Tablet with Tenofovir disoproxil can show additive effect and increase the risk or severity of kidney problems.
How to manage the interaction:
Taking Bigspas M Tablet with Tenofovir Disoproxil together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, red or black tarry stools, vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Bigspas M Tablet with Tenofovir disoproxil can show additive effect and increase the risk or severity of kidney problems.
How to manage the interaction:
Taking Bigspas M Tablet with Tenofovir Disoproxil together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, dizziness, red or black tarry stools, vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Bigspas M Tablet:
Coadministration of Bigspas M Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Bigspas M Tablet with Dabigatran can increase the risk or severity of bleeding leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Dabigatran etexilate together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any unusual bleeding or bruising, other signs of bleeding, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Bigspas M Tablet:
Taking Human immunoglobulin with Bigspas M Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Bigspas M Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
Taking Human immunoglobulin with Bigspas M Tablet, may raise the risk of kidney problems.
How to manage the interaction:
There may be a possibility of interaction between Human immunoglobulin and Bigspas M Tablet, but it can be taken if prescribed by a doctor. However, if you experience nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, or an irregular heart rhythm, consult a doctor. Do not discontinue any medications without consulting a doctor.
How does the drug interact with Bigspas M Tablet:
Coadministration of Bigspas M Tablet with Deferasirox can increase the risk or severity of gastric bleeding.
How to manage the interaction:
Taking Bigspas M Tablet with Deferasirox together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of increased or decreased urination, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Coadministration of Bigspas M Tablet with Deferasirox can increase the risk or severity of gastric bleeding.
How to manage the interaction:
Taking Bigspas M Tablet with Deferasirox together can result in an interaction, it can be taken if your doctor has advised it. However, if you notice any symptoms of increased or decreased urination, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
How does the drug interact with Bigspas M Tablet:
Using Bigspas M Tablet and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Bigspas M Tablet with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Using Bigspas M Tablet and baricitinib together may increase the risk of gastrointestinal perforation (a serious health condition where a hole develops through the stomach or intestine).
How to manage the interaction:
Co-administration of Bigspas M Tablet with Baricitinib can result in an interaction, but it can be taken if your doctor has advised it. If you notice any signs like severe stomach pain, fever, or vomiting, consult a doctor. Do not stop using any medications without talking to a doctor.
Severe
How does the drug interact with Bigspas M Tablet:
Co-administration of Bigspas M Tablet with Ibrutinib can increase the risk or severity of bleeding, leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Ibrutinib together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Bigspas M Tablet with Ibrutinib can increase the risk or severity of bleeding, leading to serious blood loss.
How to manage the interaction:
Taking Bigspas M Tablet with Ibrutinib together can result in an interaction, it can be taken if a doctor has advised it. However, if you notice any symptoms of unusual bleeding or bruising, dizziness, lightheadedness, red or black tarry stools, coughing up or vomiting blood, severe headache, and weakness, you should contact a doctor immediately. Do not stop using any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
BIGSPAS M TABLET Substitute
Product Substitutes
Alcohol
Unsafe
You are recommended not to consume alcohol along with BIGSPAS M TABLET as it contains mefenamic acid, which can together damage your liver severely.
Pregnancy
Caution
BIGSPAS M TABLET should be used during pregnancy only if the potential benefit overweighs potential risk to the fetus.
Breast Feeding
Caution
BIGSPAS M TABLET should not be used if you are breast-feeding. BIGSPAS M TABLET passes into breast milk, so it is not recommended for use during breast-feeding unless considered essential by your doctor.
Driving
Unsafe
BIGSPAS M TABLET may cause dizziness, drowsiness and visual disturbances, which may affect their ability to drive or operate machinery. Make sure you are not affected before driving or operating machinery.
Liver
Caution
BIGSPAS M TABLET to be taken with caution, especially if you have a history of Liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
BIGSPAS M TABLET to be taken with caution, especially if you have a history of Kidney diseases/conditions. The dose may have to be adjusted by your doctor.
Children
Unsafe
BIGSPAS M TABLET is not to be used in children below 12 years of age.
Have a query?
Customers Also Bought
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
